Literature DB >> 8164500

The effect of anti-tumor necrosis factor (TNF)-alpha monoclonal antibody on allergic cutaneous late phase reaction in mice.

T Sakurai1, N Inagaki, H Nagai.   

Abstract

Biphasic cutaneous reaction with peak response at 1 (early phase) and 24 to 48 hour (late phase) was elicited by epicutaneous challenge with antigen in actively and passively sensitized mice. Mice were actively immunized with dinitrophenylated (DNP) ascaris antigen and challenged with dinitrofluorobenzene (DNFB). Passively sensitization was carried out by the injection of monoclonal anti-DNP-IgE antibody into mice and challenge was elicited with DNFB. Prednisolone at doses of 3 to 10 mg/kg clearly inhibited both early and late phase reactions in either sensitized mice. Monoclonal anti-tumor necrosis factor (TNF)-alpha antibody inhibited the late phase cutaneous reaction in actively sensitized mice. Anti-interleukin-5 (IL-5) monoclonal antibody has no effect on both phase reactions in either actively and passively sensitized animals. These results indicate the possible participation of TNF-alpha in allergic cutaneous late phase reaction in actively sensitized mice.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8164500     DOI: 10.1016/0024-3205(94)00859-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.

Authors:  Youngmi Kim; Kyungjong Kim; Deokbum Park; Eunmi Lee; Hansoo Lee; Yun-Sil Lee; Jongseon Choe; Dooil Jeoung
Journal:  J Biol Chem       Date:  2012-06-07       Impact factor: 5.157

2.  TNF-alpha participates in an IgE-mediated cutaneous reaction in mast cell deficient, WBB6F1-W/Wv mice.

Authors:  H Nagai; T Sakurai; T Abe; A Matsuo; K Musoh; M Tsunematsu; N Inagaki
Journal:  Inflamm Res       Date:  1996-03       Impact factor: 4.575

3.  Inhibition of IgE-dependent mouse triphasic cutaneous reaction by a boiling water fraction separated from mycelium of Phellinus linteus.

Authors:  Naoki Inagaki; Tomonori Shibata; Tomokazu Itoh; Tomohiro Suzuki; Hiroyuki Tanaka; Tomoyuki Nakamura; Yukihito Akiyama; Hirokazu Kawagishi; Hiroichi Nagai
Journal:  Evid Based Complement Alternat Med       Date:  2005-09       Impact factor: 2.629

4.  Modulation of Immune Functions by Foods.

Authors:  Shuichi Kaminogawa; Masanobu Nanno
Journal:  Evid Based Complement Alternat Med       Date:  2004-10-06       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.